News for Healthier Living

Bleeding Risk with Apixaban and Dabigatran Similar to Aspirin

A systematic review and meta-analysis estimating the differences in bleeding risks between therapeutic-dose non-vitamin K oral anticoagulants (NOACs) and single antiplatelet therapy (aspirin) found that rates of major bleeding for therapeutic-dose apixaban and dabigatran were similar to low-dose aspirin, but rates were higher for rivaroxaban.

February 10, 2025


February 21 2025

February 20 2025

February 19 2025

February 18 2025

February 17 2025

February 16 2025

February 15 2025

February 14 2025

February 13 2025

February 12 2025

February 11 2025

February 10 2025

February 9 2025

February 8 2025